• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由抗凝血酶Rouen-VI(187位天冬酰胺突变为天冬氨酸)的热不稳定构象变化引起的血栓栓塞性疾病

Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen-VI (187 Asn-->Asp).

作者信息

Bruce D, Perry D J, Borg J Y, Carrell R W, Wardell M R

机构信息

Department of Haematology, University of Cambridge, United Kingdom.

出版信息

J Clin Invest. 1994 Dec;94(6):2265-74. doi: 10.1172/JCI117589.

DOI:10.1172/JCI117589
PMID:7989582
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC330053/
Abstract

A new variant of antithrombin (Rouen-VI, 187 Asn-->Asp) with increased heparin affinity was shown to have normal inhibitory activity which decreased slowly at 4 degrees C and rapidly at 41 degrees C. On electrophoresis the freshly isolated variant had an anodal shift relative to native antithrombin due to the mutation. A further anodal transition occurred after either prolonged storage at 4 degrees C or incubation at 41 degrees C due to the formation of a new inactive uncleaved component with properties characteristic of L-form (latent) antithrombin. At the same time, polymerization also occurred with a predominance of di-, tri-, and tetra-mers. These findings fit with the observed mutation of the conserved asparagine (187) in the F-helix destabilizing the underlying A-sheet of the molecule. Evidence of A-sheet perturbation is provided by the increased rate of peptide insertion into the A-sheet and by the decreased vulnerability of the reactive loop to proteolysis. The spontaneous formation of both L-antithrombin and polymers is consistent with our crystal structure of intact antithrombin where L-form and active antithrombin are linked together as dimers. The nature of this linkage favors a mechanism of polymerization whereby the opening of the A-sheet, to give incorporation of the reactive center loop, is accompanied by the bonding of the loop of one molecule to the C-sheet of the next. The accelerated lability of antithrombin Rouen-VI at 41 versus 37 degrees C provides an explanation for the clinical observation that episodes of thrombosis were preceded by unrelated pyrexias.

摘要

一种具有增强肝素亲和力的抗凝血酶新变体(鲁昂 - VI,187位天冬酰胺突变为天冬氨酸)显示具有正常的抑制活性,该活性在4℃时缓慢下降,在41℃时迅速下降。在电泳中,由于突变,新分离的变体相对于天然抗凝血酶有阳极迁移。在4℃长时间储存或在41℃孵育后,由于形成了一种具有L型(潜伏)抗凝血酶特性的新的无活性未切割成分,会发生进一步的阳极转变。与此同时,还发生了聚合反应,主要形成二聚体、三聚体和四聚体。这些发现与在F - 螺旋中保守天冬酰胺(187)的观察到的突变相符合,该突变使分子的基础A - 片层不稳定。肽插入A - 片层的速率增加以及反应环对蛋白水解的敏感性降低,提供了A - 片层扰动的证据。L - 抗凝血酶和聚合物的自发形成与我们完整抗凝血酶的晶体结构一致,其中L型和活性抗凝血酶以二聚体形式连接在一起。这种连接的性质有利于一种聚合机制,即A - 片层打开以纳入反应中心环时,一个分子的环与下一个分子的C - 片层结合。抗凝血酶鲁昂 - VI在41℃与37℃相比加速失活,为临床观察到的血栓形成发作之前出现无关发热提供了解释。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/330053/26d20e74053c/jcinvest00490-0101-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/330053/2847c3e510a8/jcinvest00490-0097-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/330053/aa13587cd3c0/jcinvest00490-0098-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/330053/4822ef7f4d71/jcinvest00490-0098-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/330053/ef8b0e4d3f2a/jcinvest00490-0099-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/330053/4fac8c9534e5/jcinvest00490-0100-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/330053/6936dd10bcad/jcinvest00490-0101-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/330053/26d20e74053c/jcinvest00490-0101-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/330053/2847c3e510a8/jcinvest00490-0097-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/330053/aa13587cd3c0/jcinvest00490-0098-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/330053/4822ef7f4d71/jcinvest00490-0098-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/330053/ef8b0e4d3f2a/jcinvest00490-0099-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/330053/4fac8c9534e5/jcinvest00490-0100-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/330053/6936dd10bcad/jcinvest00490-0101-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/330053/26d20e74053c/jcinvest00490-0101-b.jpg

相似文献

1
Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen-VI (187 Asn-->Asp).由抗凝血酶Rouen-VI(187位天冬酰胺突变为天冬氨酸)的热不稳定构象变化引起的血栓栓塞性疾病
J Clin Invest. 1994 Dec;94(6):2265-74. doi: 10.1172/JCI117589.
2
Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1.L-抗凝血酶的制备性诱导与表征:潜在纤溶酶原激活物抑制剂-1的结构同源物
Biochemistry. 1997 Oct 21;36(42):13133-42. doi: 10.1021/bi970664u.
3
Antithrombins Wibble and Wobble (T85M/K): archetypal conformational diseases with in vivo latent-transition, thrombosis, and heparin activation.抗凝血酶Wibble和Wobble(T85M/K):具有体内潜伏转变、血栓形成和肝素激活的典型构象疾病。
Blood. 1998 Oct 15;92(8):2696-706.
4
Antithrombin-TRI (Ala382 to Thr) causing severe thromboembolic tendency undergoes the S-to-R transition and is associated with a plasma-inactive high-molecular-weight complex of aggregated antithrombin.导致严重血栓栓塞倾向的抗凝血酶-TRI(丙氨酸382突变为苏氨酸)发生了从S型到R型的转变,并与聚集的抗凝血酶的血浆非活性高分子量复合物有关。
Br J Haematol. 1995 Mar;89(3):589-601. doi: 10.1111/j.1365-2141.1995.tb08368.x.
5
Deletion of P1 arginine in a novel antithrombin variant (antithrombin London) abolishes inhibitory activity but enhances heparin affinity and is associated with early onset thrombosis.在一种新型抗凝血酶变体(抗凝血酶伦敦)中删除P1精氨酸会消除抑制活性,但会增强肝素亲和力,并与早发性血栓形成有关。
J Biol Chem. 2003 Apr 18;278(16):13688-95. doi: 10.1074/jbc.M300062200. Epub 2003 Feb 18.
6
Two novel antithrombin variants, Asn187Asp and Asn187Lys, indicate a functional role for asparagine 187.
Blood Coagul Fibrinolysis. 1995 Feb;6(1):51-4. doi: 10.1097/00001721-199502000-00008.
7
The conformational basis of thrombosis.血栓形成的构象基础。
Thromb Haemost. 2001 Jul;86(1):14-22.
8
Biological implications of a 3 A structure of dimeric antithrombin.二聚体抗凝血酶3A结构的生物学意义
Structure. 1994 Apr 15;2(4):257-70. doi: 10.1016/s0969-2126(00)00028-9.
9
Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to Ser.基于精氨酸47提出的抗凝血酶中的肝素结合位点。一种新的变体鲁昂-II,47位精氨酸突变为丝氨酸。
J Clin Invest. 1988 Apr;81(4):1292-6. doi: 10.1172/JCI113447.
10
Detection of conformational transformation of antithrombin in blood with crossed immunoelectrophoresis: new application for a classical method.用交叉免疫电泳检测血液中抗凝血酶的构象转变:经典方法的新应用。
J Lab Clin Med. 2003 Nov;142(5):298-305. doi: 10.1016/S0022-2143(03)00136-7.

引用本文的文献

1
SERPINC1 c.1247dupC: a novel SERPINC1 gene mutation associated with familial thrombosis results in a secretion defect and quantitative antithrombin deficiency.SERPINC1基因c.1247dupC:一种与家族性血栓形成相关的新型SERPINC1基因突变,导致分泌缺陷和抗凝血酶定量缺乏。
Thromb J. 2024 Feb 12;22(1):19. doi: 10.1186/s12959-024-00589-5.
2
Identification and characterization of two SERPINC1 mutations causing congenital antithrombin deficiency.导致先天性抗凝血酶缺乏症的两个SERPINC1突变的鉴定与特征分析
Thromb J. 2023 Jan 9;21(1):3. doi: 10.1186/s12959-022-00443-6.
3
Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and Thrombosis.

本文引用的文献

1
Effect of the Z mutation on the physical and inhibitory properties of alpha 1-antitrypsin.Z突变对α1-抗胰蛋白酶物理性质和抑制特性的影响。
Biochemistry. 1993 Jan 19;32(2):500-8. doi: 10.1021/bi00053a014.
2
A hinge region mutation in C1-inhibitor (Ala436-->Thr) results in nonsubstrate-like behavior and in polymerization of the molecule.C1抑制剂中的一个铰链区突变(丙氨酸436→苏氨酸)导致分子出现非底物样行为并发生聚合。
J Biol Chem. 1993 Aug 25;268(24):18088-94.
3
Alpha 1-antitrypsin Siiyama (Ser53-->Phe). Further evidence for intracellular loop-sheet polymerization.
抗凝血丝氨酸蛋白酶抑制剂:止血和血栓形成的内源性调节因子。
Front Cardiovasc Med. 2022 May 3;9:878199. doi: 10.3389/fcvm.2022.878199. eCollection 2022.
4
Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays.两种影响丝氨酸蛋白酶抑制剂 C1 蛋白 N 连接糖基化的 Asn224 变异导致严重的血栓形成倾向,而功能检测无法发现这一情况。
Blood. 2022 Jul 14;140(2):140-151. doi: 10.1182/blood.2021014708.
5
The Serpin Superfamily and Their Role in the Regulation and Dysfunction of Serine Protease Activity in COPD and Other Chronic Lung Diseases.丝氨酸蛋白酶抑制剂超家族及其在 COPD 和其他慢性肺部疾病中对丝氨酸蛋白酶活性的调节和功能障碍的作用。
Int J Mol Sci. 2021 Jun 14;22(12):6351. doi: 10.3390/ijms22126351.
6
Intrahepatic heteropolymerization of M and Z alpha-1-antitrypsin.肝内 M 和 Z 型α-1-抗胰蛋白酶的多聚化。
JCI Insight. 2020 Jul 23;5(14):135459. doi: 10.1172/jci.insight.135459.
7
COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis.新型冠状病毒肺炎、低分子量肝素与血液透析
Kidney Blood Press Res. 2020;45(3):357-362. doi: 10.1159/000508460. Epub 2020 May 25.
8
PKC (Protein Kinase C)-δ Modulates AT (Antithrombin) Signaling in Vascular Endothelial Cells.蛋白激酶 C-δ调节血管内皮细胞中的抗凝血酶信号通路。
Arterioscler Thromb Vasc Biol. 2020 Jul;40(7):1748-1762. doi: 10.1161/ATVBAHA.120.314479. Epub 2020 May 14.
9
Recurrent mutations in a hotspot associate with venous thrombosis without apparent antithrombin deficiency.热点区域的复发性突变与无明显抗凝血酶缺乏的静脉血栓形成相关。
Oncotarget. 2017 Sep 28;8(48):84417-84425. doi: 10.18632/oncotarget.21365. eCollection 2017 Oct 13.
10
Conformational preludes to the latency transition in PAI-1 as determined by atomistic computer simulations and hydrogen/deuterium-exchange mass spectrometry.原子模拟计算和氘代/氢交换质谱法测定的 PAI-1 潜伏态转变的构象前序。
Sci Rep. 2017 Jul 26;7(1):6636. doi: 10.1038/s41598-017-06290-0.
α1-抗胰蛋白酶石山型(丝氨酸53→苯丙氨酸)。细胞内环-片层聚合的进一步证据。
J Biol Chem. 1993 Jul 25;268(21):15333-5.
4
Crystal structure of cleaved bovine antithrombin III at 3.2 A resolution.分辨率为3.2埃的裂解牛抗凝血酶III晶体结构。
J Mol Biol. 1993 Jul 5;232(1):223-41. doi: 10.1006/jmbi.1993.1378.
5
Crystallization and preliminary X-ray diffraction analysis of two conformations of intact human antithrombin.
J Mol Biol. 1993 Dec 20;234(4):1253-8. doi: 10.1006/jmbi.1993.1676.
6
C1 inhibitor mutations which affect intracellular transport and secretion in type I hereditary angioedema.
Behring Inst Mitt. 1993 Dec(93):120-4.
7
Biological implications of a 3 A structure of dimeric antithrombin.二聚体抗凝血酶3A结构的生物学意义
Structure. 1994 Apr 15;2(4):257-70. doi: 10.1016/s0969-2126(00)00028-9.
8
Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory reactive loop.未裂解丝氨酸蛋白酶抑制剂的晶体结构揭示了抑制性反应环的构象。
Nat Struct Biol. 1994 Apr;1(4):251-8. doi: 10.1038/nsb0494-251.
9
The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions.完整和裂解的人抗凝血酶III复合物作为丝氨酸蛋白酶抑制剂-蛋白酶相互作用的模型。
Nat Struct Biol. 1994 Jan;1(1):48-54. doi: 10.1038/nsb0194-48.
10
Binding of high affinity heparin to antithrombin III. Stopped flow kinetic studies of the binding interaction.高亲和力肝素与抗凝血酶III的结合。结合相互作用的停流动力学研究。
J Biol Chem. 1981 Nov 10;256(21):11073-9.